2016
Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach
ONDRÚŠ, Tomáš; Jozef BARTUNEK; Marc VANDERHEYDEN; B STOCKMAN; Martin KOTRC et al.Základní údaje
Originální název
Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach
Autoři
ONDRÚŠ, Tomáš; Jozef BARTUNEK; Marc VANDERHEYDEN; B STOCKMAN; Martin KOTRC; Frank VAN PRAET; Guy VAN CAMP; Patrick LECOMTE; Yujing MO a Martin PENICKA
Vydání
Interactive CardioVascular and Thoracic Surgery, OXFORD, OXFORD UNIV PRESS, 2016, 1569-9293
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.857
Označené pro přenos do RIV
Ne
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
MitraClip; Mitral valve repair; Functional mitral regurgitation; Outcome
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 31. 8. 2017 12:29, Soňa Böhmová
Anotace
V originále
To compare the outcomes of MitraClip versus minimally invasive surgical mitral valve repair in high-risk patients with significant functional mitral regurgitation (FMR) and severe heart failure in a centre having pilot versus extensive experience with the MitraClip and the minimally invasive surgical approach, respectively. The MitraClip group consisted of 24 high-surgical-risk patients [age 75 +/- 9 years, 75% males, NYHA III/IV 88%, left ventricular (LV) ejection fraction 31 +/- 9%, EuroSCORE II 18 +/- 14%], while the surgical group consisted of 48 patients matched for age, NYHA class and LV ejection fraction. Patients undergoing MitraClip versus those undergoing surgical repair showed higher prevalence of ischaemic LV dysfunction and larger LV end-diastolic diameter (both P < 0.05). Both the MitraClip and the surgical repair groups had similar 30-day mortality rates (4 vs 13%, P = 0.41) and prevalence of serious adverse events (25 vs 38%, P = 0.43). The median follow-up was 1028 days (IQR: 272-1564 days) in the MitraClip group and 890 days (IQR: 436-1381 days) in the surgical group (P = 0.95). Total all-cause mortality (54 vs 60%, log-rank P = 0.64) and rates of rehospitalizations for heart failure (42 vs 29%, log-rank P = 0.68) did not differ significantly between groups. Both techniques were associated with significant decrease in NYHA class and severity of FMR (P < 0.001 for all) and with a similar degree of stabilization of LV remodelling (P = NS). Despite the significant baseline differences in accumulated expertise and risk profile between the surgical and the MitraClip groups, both minimally invasive techniques were associated with similar 30-day and long-term outcomes.